<DOC>
	<DOCNO>NCT00405587</DOCNO>
	<brief_summary>The primary objective FIH study ass safety pharmacokinetics PLX4032 patient solid tumor . The secondary objective ass pharmacodynamic activity pair biopsy specimen obtain patient malignant melanoma V600E BRAF oncogenic mutation .</brief_summary>
	<brief_title>Safety Study PLX4032 Patients With Solid Tumors</brief_title>
	<detailed_description>Activating mutation BRAF gene observe variety cancer , include 55-68 % malignant melanoma . In general , oncogenic mutation BRAF correlate poor outcome . PLX4032 compound selectively inhibit oncogenic B-Raf kinase . Two extension cohort patient confirm V600E mutation recruit , consist advanced melanoma metastatic colorectal carcinoma .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Solid tumor confirm histologically whose tumor refractory standard therapy , standard curative therapy exist Patients pair melanoma biopsy plan must V600E+ BRAF mutation confirm prior administration PLX4032 Previous chemotherapy , immunotherapy , radiation therapy must complete least 2 week prior start PLX4032 therapy , associate toxicity must resolve prior administration PLX4032 Patients Extension cohort ( melanoma adenocarcinoma colon rectum ) must V600E+ BRAF mutation measurable disease ( RECIST V 1.0 criterion ) prior administration PLX4032 . All patient enrol must provide archival fresh melanoma tumor biopsy confirmation V600E+ BRAF mutation status TaqMan assay ECOG performance status 0 1 Life expectancy â‰¥ 3 month Adequate hematologic , hepatic , renal function Brain metastases progress document stable less 3 month , systemic corticosteroid require Investigational drug use within 28 day first dose PLX4032 Uncontrolled intercurrent illness Refractory nausea vomiting , malabsorption , significant bowel resection would preclude adequate absorption</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>